Navigation Links
Sinovac Announces Postponement of Annual General Meeting
Date:8/20/2007

BEIJING, Aug. 20 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a leading provider of biopharmaceutical products in China, notified its shareholders today that the Annual General Meeting of shareholders, convened for August 21, 2007, has been postponed due the geographical nature of its shareholders and technical difficulties with the mailing of proxy materials. The Company is currently working to ensure that shareholders receive necessary proxy materials in an efficient manner and will provide an update on the date of the postponed meeting as quickly as possible, to be held before the end of September 2007 with an unchanged agenda and venue.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccines include Healive(TM) (hepatitis A), Bilive(TM) (combined hepatitis A and B) and Anflu(TM) (influenza). Sinovac is currently developing human vaccines against the H5N1 strain of pandemic influenza, Japanese encephalitis and SARS. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinova
'/>"/>

SOURCE Sinovac Biotech Ltd.

Copyright©2007 PR Newswire.

Page: 1 2

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... , June 3, 2015  inVentiv ... development and comprehensive commercialization services, today announced ... as President, inVentiv Health Clinical Division and ... is a seasoned veteran within the CRO ... clinical development, technology and the development of ...
(Date:6/3/2015)... Minn. , June 3, 2015 ... that supports the entire spectrum of clinical research, is ... iMedNet eClinical technology platform will ... by the end of this month.  iMedNet ... – built from the ground up by MedNet Solutions, ...
(Date:6/3/2015)... ROOSEVELT, N.J. , June 3, 2015 /PRNewswire/ ... Life Science industries, will host its 6 th ... and Exposition Center at Raritan Center in ... 2015.  Event sponsors include Novo Nordisk, Covance, Actavis ... companies that will be exhibiting are Johnson & ...
(Date:6/3/2015)... New York and London (PRWEB) June 03, 2015 ... Applications (NCSA) recently set a new world record ... 102,000 cores on the Blue Waters supercomputer. ... tool used across many industries to stimulate innovation ... NCSA’s Private Sector Program and Blue Waters manufacturer ...
Breaking Biology Technology:inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 2inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 3inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 4inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health 5MedNet Announces "2015 Feature 1" Release Of iMedNet eClinical 2AstraZeneca Added as Sponsor for Industry Leading Life Science Hiring Event 2NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 2NCSA Scales CD-adapco’s STAR-CCM+ to New World Record of 102,000 Cores on Blue Waters 3
... ... ... ... ...
... ... Technologies for Quantitative, Reproducible Imaging and Enhancing Fluorescence Correlation Spectroscopy Data , ... (PRWEB) February 19, 2010 -- ... life sciences, will offer two educational presentations at the 2010 Biophysical Annual Meeting. The ...
... ATLANTA , Feb. 18 GeoVax ... Atlanta -based, biopharmaceutical company developing vaccines for diseases caused ... the results of a preclinical study on a prototype HIV/AIDS ... (CROI) in San Francisco . , The oral ...
Cached Biology Technology:CHMP Adopts Negative Opinion for ZEFTERA(TM) 2CHMP Adopts Negative Opinion for ZEFTERA(TM) 3Photometrics to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting 2Photometrics to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting 3Photometrics to Offer Presentations on EMCCD Bio-Imaging Advances at 2010 Biophysical Annual Meeting 4GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 2GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 3GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 4GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 5GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies 6
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... 10, 2011For physicians within several medical specialties, including ... patient recommendations for dietary supplements are quite common, ... Journal , a peer-reviewed, on-line journal that focuses ... The 2008 "Lifesupplemented" Healthcare Professionals (HCP) Impact Study ...
... study by scientists from Maryland and Colorado using American ... that they are at greater risk from poisoning from ... in Environmental Toxicology and Chemistry , considers the ... restrictions on the use of similar pesticides. ...
... readers, lasers have been used in a myriad of applications ... with the work being done in Jeff Gelles, Lab at ... to study the splicing of pre-messenger RNA molecules, an essential ... life. This process of splicing is carried out by a ...
Cached Biology News:Study finds usage of, recommendations for supplements common within various physician specialties 2American birds of prey at higher risk of poisoning from pest control chemicals 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 3
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
WTAP Antibody...
Biology Products: